{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:33:20Z","timestamp":1722386000963},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,30]]},"DOI":"10.7759\/cureus.65777","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T20:01:26Z","timestamp":1722369686000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of West Nile Virus Neuroinvasive Disease Presenting With Isolated Diplopia"],"prefix":"10.7759","author":[{"given":"Elizabeth A","family":"Olsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander K","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-2760-0_1","article-title":"Introduction to West Nile virus","volume":"2585","author":"Karim SU","year":"2023","unstructured":"Karim SU, Bai F. Introduction to West Nile virus. Methods Mol Biol. 2023, 2585:1-7. 10.1007\/978-1-0716-2760-0_1","journal-title":"Methods Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4065\/78.9.1137","article-title":"West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention","volume":"78","author":"Sampathkumar P","year":"2003","unstructured":"Sampathkumar P. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc. 2003, 78:1137-43; quiz 1144. 10.4065\/78.9.1137","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.11-0502","article-title":"Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010","volume":"86","author":"Gibney KB","year":"2012","unstructured":"Gibney KB, Colborn J, Baty S, et al.. Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010. Am J Trop Med Hyg. 2012, 86:895-901. 10.4269\/ajtmh.2012.11-0502","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EI10-0021-2016","article-title":"West Nile virus infection","volume":"4","author":"Sejvar JJ","year":"2016","unstructured":"Sejvar JJ. West Nile virus infection. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.EI10-0021-2016","journal-title":"Microbiol Spectr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0717","article-title":"Demographic and clinical factors associated with persistent symptoms after West Nile virus infection","volume":"83","author":"Cook RL","year":"2010","unstructured":"Cook RL, Xu X, Yablonsky EJ, et al.. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg. 2010, 83:1133-6. 10.4269\/ajtmh.2010.09-0717","journal-title":"Am J Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute west nile virus infection","volume":"198","author":"Busch MP","year":"2008","unstructured":"Busch MP, Kleinman SH, Tobler LH, et al.. Virus and antibody dynamics in acute west nile virus infection. J Infect Dis. 2008, 198:984-93. 10.1086\/591467","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit278","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a)","volume":"57","author":"Baron EJ","year":"2013","unstructured":"Baron EJ, Miller JM, Weinstein MP, et al.. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013, 57:e22-e121. 10.1093\/cid\/cit278","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.12-0113","article-title":"Medical risk factors for severe West Nile Virus disease, United States, 2008-2010","volume":"87","author":"Lindsey NP","year":"2012","unstructured":"Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile Virus disease, United States, 2008-2010. Am J Trop Med Hyg. 2012, 87:179-84. 10.4269\/ajtmh.2012.12-0113","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/v6020606","article-title":"Clinical manifestations and outcomes of West Nile virus infection","volume":"6","author":"Sejvar JJ","year":"2014","unstructured":"Sejvar JJ. Clinical manifestations and outcomes of West Nile virus infection. Viruses. 2014, 6:606-23. 10.3390\/v6020606","journal-title":"Viruses"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.4.511","article-title":"Neurologic manifestations and outcome of West Nile virus infection","volume":"290","author":"Sejvar JJ","year":"2003","unstructured":"Sejvar JJ, Haddad MB, Tierney BC, et al.. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003, 290:511-5. 10.1001\/jama.290.4.511","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.8042","article-title":"West Nile virus: review of the literature","volume":"310","author":"Petersen LR","year":"2013","unstructured":"Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013, 310:308-15. 10.1001\/jama.2013.8042","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3201\/eid1004.030783","article-title":"Mollaret-like cells in patients with West Nile virus infection","volume":"10","author":"Procop GW","year":"2004","unstructured":"Procop GW, Yen-Lieberman B, Prayson RA, Gordon SM. Mollaret-like cells in patients with West Nile virus infection. Emerg Infect Dis. 2004, 10:753-4. 10.3201\/eid1004.030783","journal-title":"Emerg Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13183","article-title":"Management of West Nile encephalitis: an uncommon complication of West Nile virus","volume":"13","author":"Alli A","year":"2021","unstructured":"Alli A, Ortiz JF, Atoot A, Atoot A, Millhouse PW. Management of West Nile encephalitis: an uncommon complication of West Nile virus. Cureus. 2021, 13:e13183. 10.7759\/cureus.13183","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2007.0109","article-title":"Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004","volume":"8","author":"Murray KO","year":"2008","unstructured":"Murray KO, Baraniuk S, Resnick M, et al.. Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. Vector Borne Zoonotic Dis. 2008, 8:167-74. 10.1089\/vbz.2007.0109","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3201\/eid2511.190537","article-title":"Lack of efficacy of high-titered immunoglobulin in patients with West Nile virus central nervous system disease","volume":"25","author":"Gnann JW Jr","year":"2019","unstructured":"Gnann JW Jr, Agrawal A, Hart J, et al.. Lack of efficacy of high-titered immunoglobulin in patients with West Nile virus central nervous system disease. Emerg Infect Dis. 2019, 25:2064-73. 10.3201\/eid2511.190537","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3201\/eid0704.010414","article-title":"Clinical characteristics of the West Nile fever outbreak, Israel, 2000","volume":"7","author":"Chowers MY","year":"2001","unstructured":"Chowers MY, Lang R, Nassar F, et al.. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001, 7:675-8. 10.3201\/eid0704.010414","journal-title":"Emerg Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2019.104213","article-title":"Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - result of a multinational ID-IRI study","volume":"122","author":"Popescu CP","year":"2020","unstructured":"Popescu CP, Florescu SA, Hasbun R, et al.. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - result of a multinational ID-IRI study. J Clin Virol. 2020, 122:104213. 10.1016\/j.jcv.2019.104213","journal-title":"J Clin Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7001a1","article-title":"Surveillance for West Nile virus disease - United States, 2009-2018","volume":"70","author":"McDonald E","year":"2021","unstructured":"McDonald E, Mathis S, Martin SW, Staples JE, Fischer M, Lindsey NP. Surveillance for West Nile virus disease - United States, 2009-2018. MMWR Surveill Summ. 2021, 70:1-15. 10.15585\/mmwr.ss7001a1","journal-title":"MMWR Surveill Summ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05760-7","article-title":"Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients","volume":"21","author":"Koch M","year":"2021","unstructured":"Koch M, Pozsgai \u00c9, So\u00f3s V, et al.. Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients. BMC Infect Dis. 2021, 21:65. 10.1186\/s12879-020-05760-7","journal-title":"BMC Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3201\/eid1008.030879","article-title":"Long-term prognosis for clinical West Nile virus infection","volume":"10","author":"Klee AL","year":"2004","unstructured":"Klee AL, Maidin B, Edwin B, et al.. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis. 2004, 10:1405-11. 10.3201\/eid1008.030879","journal-title":"Emerg Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265570-a-case-of-west-nile-virus-neuroinvasive-disease-presenting-with-isolated-diplopia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T20:01:31Z","timestamp":1722369691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265570-a-case-of-west-nile-virus-neuroinvasive-disease-presenting-with-isolated-diplopia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.65777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}